Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000406769 | SCV000399413 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000609860 | SCV000726014 | likely benign | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000609860 | SCV002437735 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278471 | SCV002565420 | likely benign | Ehlers-Danlos syndrome | 2022-08-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436175 | SCV002676621 | likely benign | Cardiovascular phenotype | 2022-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |